Infusion Brands International, Inc. announced that on August 10, 2012, it has entered into an agreement and plan of merger with Ronco Holdings, Inc., CD3 Holdings, Inc., the holder of all of the issued and outstanding common stock of Ronco, Ronco Brands, Inc., a Nevada corporation and Infusion's newly formed wholly owned subsidiary and Vicis Capital Master Fund, Infusion's principal stockholder. On the closing date, Robert DeCecco shall resign from his position as Chairman of Infusion's Board of Directors (but remain a director of Infusion along with Shad Stastney and Keith Hughes) and CD3 will have the right to appoint a new Chairman. Additionally, on the Closing Date, CD3 shall appoint two additional nominees to Infusion's Board of Directors and shall appoint Tod Barrett to the position of co- Chief Executive Officer, who will serve alongside Mr. DeCecco as co-Chief Executive Officer of Infusion.